| Prev Close: | 47.61 |
|---|---|
| Open: | 48.92 |
| Bid: | 48.48 x 400 |
| Ask: | 48.74 x 600 |
| 1y Target Est: | 51.79 |
| Beta: | 0.55 |
| Next Earnings Date: | 28-Oct-13 |
| Day's Range: | 48.15 - 49.23 |
|---|---|
| 52wk Range: | 40.02 - 50.16 |
| Volume: | 27,310,889 |
| Avg Vol (3m): | 11,894,200 |
| Market Cap: | 142.63B |
| P/E (ttm): | 29.19 |
| EPS (ttm): | 1.67 |
| Div & Yield: | 1.72 (3.60%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Merck drug triggers response in 24 pct of lung cancer patientsReuters(Tue 5:29PM EDT)
- At the Close: Stocks Ignore Shutdown; Small Caps Gain Most in Three Weeksat Barrons.com(Tue 5:25PM EDT)
- Merck to cut 8,500 more jobsAP(Tue 5:04PM EDT)
- MERCK & CO. INC. Files SEC form 8-K, Costs Associated with Exit or Disposal ActivitiesEDGAR Online(Tue 5:03PM EDT)
- Health sector sits atop S&P 500 on Obamacare's first dayat MarketWatch(Tue 5:00PM EDT)
- Merck to cut 8,500 additional jobsat Financial Times(Tue 4:54PM EDT)
- First Government Shutdown in 17 Years Sends Stocks Rocketing Higherat Minyanville(Tue 4:50PM EDT)
- [video] Merck to Fire 8,500 in Strategy Overhaulat Bloomberg(Tue 4:49PM EDT)
- US STOCKS-Wall St rebounds as gov't shutdown seen short-livedReuters(Tue 4:47PM EDT)
- Icahn jawboning adds 2.4% to Apple’s stockat MarketWatch(Tue 4:43PM EDT)
- Merck Now #21 Largest Company, Surpassing Philip Morrisat Forbes(Tue 4:38PM EDT)
- [$$] Merck Slashes Jobsat The Wall Street Journal(Tue 4:32PM EDT)
- Stocks rise on hopes for a limited shutdownat MarketWatch(Tue 4:30PM EDT)
- On The Fly: Closing Wrapat theflyonthewall.com(Tue 4:22PM EDT)
- Stocks close higher as investors shrug off shutdown; Apple jumps 2%at CNBC(Tue 4:20PM EDT)
Press Releases
- Interim Data for Merck’s MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Previously Treated Patients with Non-Small Cell Lung Cancer to be Presented at 15th World Conference on Lung CancerBusiness Wire(Tue 1:00PM EDT)
- Data from Merck’s Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual MeetingBusiness Wire(Tue 10:00AM EDT)
- Merck Updates Plans for Headquarters Move in New JerseyBusiness Wire(Tue 8:30AM EDT)
Reports
- MRK: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Oct 1)
- Thomson Reuters Stock Report - MERCK & CO. , INC. (MRK-N)Thomson Reuters Stock Report(Oct 1)
- Trading Report for (MRK). A detailed report, including free correlated market...Stock Traders Daily(Oct 1)